NCT06599684View on ClinicalTrials.gov

Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy

PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 7, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Non-center Involved Diabetic Macular EdemaNon-center Involved Diabetic Macular Edema Associated With Non-proliferative Diabetic RetinopathyDiabetic RetinopathyCenter-involved Diabetic Macular EdemaCenter-involved Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy
Interventions
DRUG

INV-102

0.7% Ophthalmic Solution

Trial Locations (1)

75204

RECRUITING

MedTrials, Inc., Dallas

Sponsors

Lead Sponsor

Invirsa, Inc.
All Listed Sponsors
lead

Invirsa, Inc.

INDUSTRY